ClinicalTrials.Veeva

Menu

A Single-center, Interventional Diagnostic Study With Minimal Risks and Constraints, Aimed at Longitudinally Evaluating Serum Antibody Levels in Patients With COVID-19 According to the Severity of Their Symptoms. (COVERT)

B

Bioaster

Status

Completed

Conditions

COVID-19

Treatments

Biological: blood sample

Study type

Interventional

Funder types

Other

Identifiers

NCT06862531
2020-A02008-31

Details and patient eligibility

About

The COVERT protocol was designed to assess, through a longitudinal analysis, the level of antibodies present in the serum of patients with COVID-19, the duration and the persistence of the humoral response in correlation with the severity of the disease.

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥18 years old,
  • Patient whose Covid-19 diagnosis has been confirmed by RT-PCR test (SARS-CoV-2 positive) from a nasopharyngeal swab/broncho alveolar lavage
  • Patient whose severity of Covid-19 required hospital treatment
  • Patient whose Covid-19 form is defined as moderate (stay in general ward) or severe (stay in ICU), based on the clinical evaluation conducted by the doctor
  • Patient agreeing to participate in the study and having signed the informed consent.

Exclusion criteria

  • Adult person subject to legal protection,
  • Pregnant, parturient or breastfeeding woman
  • Person not affiliated to a social security scheme or not beneficiary of such a scheme
  • Person subject to a safeguard measure
  • Person deprived of liberty by a judicial or administrative decision and woman hospitalized without consent under Articles L.3212-1 and 3213-1, which do not fall under Article L.1122-8 of the Public Health Code.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 1 patient group

Severe
Other group
Description:
patients who developed a severe form of Covid (hospitalized in ICU in March/April 2020)
Treatment:
Biological: blood sample

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems